At meeting held on 10 June 2021
Earum Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 10 June 2021, inter alia, have approved and recommended the issuance of fully paid up bonus shares in the ratio of 1:1 (i.e. 1 fully paid up share for every 1 fully paid up equity shares held), subject to the shareholders approval through postal ballot.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
